Jennifer Doudna's CRISPR team lost a race to produce the first human cell gene edits to Feng Zhang's team at the Broad Institute/MIT by approximately two weeks, yet Doudna shared the Nobel Prize with Emmanuel Sharpentig while Zhang did not—because the Nobel was awarded for the conceptual discovery (repurposing CRISPR as a gene-editing tool) rather than for the technical demonstration on human cells.